News

Proteo’s drug substance Elafin is a natural human antagonist of elastase and proteinase-3, two potent tissue destroying enzymes, both of which participate in the inflammatory mechanism of a

AkzoNobel has posted a net income of EUR81m, or EUR0.35 per diluted share, compared to net loss of EUR7m, or EUR0.03 per diluted share, for the prior year

Victoza and Januvia are both incretin-based diabetes therapies. Victoza mimics the activity of the naturally-occurring hormone, GLP-1, while Januvia blocks the enzyme responsible for the breakdown of GLP-1

Health Canada has a 45-day screening for acceptance process of the Rresponse by their Regulatory Project Management group. The acceptance of the Response triggers a new, 150-day review

The randomised, placebo-controlled, double-blind study was presented at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting and Clinical Congress in Boston. Daiichi Sankyo said that these

Novartis Pharma claimed that following EC’s decision, the pediatric indication needs to be implemented through EU National Competent Authorities before Diovan will be available for pediatric use across

Bydureon is an investigational, extended-release medication for type 2 diabetes designed to deliver continuous therapeutic levels of exenatide in a single weekly dose. In accordance with its guidelines,

Tryton Medical said that more than 1,000 patients in Europe have been treated with the Tryton Side Branch Stent System, with more than 500 part of a registry

MannKind said that Afrezza inhalation powder is a well-tolerated, ultra rapid acting insulin, provide glucose control similar to standard insulin therapy along with weight loss and reduced incidence